ID

27501

Description

Does Caffeine Reduce Dipyridamole-Induced Protection Against Ischemia-Reperfusion Injury?; ODM derived from: https://clinicaltrials.gov/show/NCT00430170

Link

https://clinicaltrials.gov/show/NCT00430170

Keywords

Versions (1)
  1. 11/19/17 11/19/17 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

November 19, 2017

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Cardiovascular Disease NCT00430170

English

Eligibility Cardiovascular Disease NCT00430170

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
male
Description

Gender

Data type

boolean

Alias
UMLS CUI [1]
C0079399
age between 18-50yr.
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
cardiovascular disease
Description

Cardiovascular Disease

Data type

boolean

Alias
UMLS CUI [1]
C0007222
hypertension (systole > 140 mmhg, diastole > 90 mmhg)
Description

Hypertensive disease | Systolic Pressure | Diastolic blood pressure

Data type

boolean

Alias
UMLS CUI [1]
C0020538
UMLS CUI [2]
C0871470
UMLS CUI [3]
C0428883
hypercholesterolemia (random total cholesterol > 6.5 mmol/l)
Description

Hypercholesterolemia | Serum total cholesterol measurement Random

Data type

boolean

Alias
UMLS CUI [1]
C0020443
UMLS CUI [2,1]
C1445957
UMLS CUI [2,2]
C0439605
diabetes mellitus (fasting glucose > 7.0 mmol/l or random glucose > 11.0 mmol/l)
Description

Diabetes Mellitus | Serum fasting glucose measurement | Serum random glucose measurement

Data type

boolean

Alias
UMLS CUI [1]
C0011849
UMLS CUI [2]
C0583334
UMLS CUI [3]
C0583333
asthma (recurrent episodes of dyspnea and wheezing, or usage of prescribed inhalation medication: i.e. corticosteroids or b2-agonists)
Description

Asthma | Dyspnea Recurrent episode | Wheezing Recurrent episode | Inhalation Drug Administration prescribed | Adrenal Cortex Hormones | beta2-Adrenergic Agonist

Data type

boolean

Alias
UMLS CUI [1]
C0004096
UMLS CUI [2,1]
C0013404
UMLS CUI [2,2]
C0443287
UMLS CUI [3,1]
C0043144
UMLS CUI [3,2]
C0443287
UMLS CUI [4,1]
C0001559
UMLS CUI [4,2]
C0278329
UMLS CUI [5]
C0001617
UMLS CUI [6]
C2917450
participation in any clinical trial during the last 60 days prior to this study.
Description

Study Subject Participation Status

Data type

boolean

Alias
UMLS CUI [1]
C2348568
administration of two doses of annexin a5 (0,1mg; 450mbq) during the last 5 years prior to this study.
Description

Annexin A5 Dose Quantity

Data type

boolean

Alias
UMLS CUI [1,1]
C0059249
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C1265611
Back to the top of the page

Similar models

Eligibility Cardiovascular Disease NCT00430170

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Gender
Item
male
boolean
C0079399 (UMLS CUI [1])
Age
Item
age between 18-50yr.
boolean
C0001779 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Cardiovascular Disease
Item
cardiovascular disease
boolean
C0007222 (UMLS CUI [1])
Hypertensive disease | Systolic Pressure | Diastolic blood pressure
Item
hypertension (systole > 140 mmhg, diastole > 90 mmhg)
boolean
C0020538 (UMLS CUI [1])
C0871470 (UMLS CUI [2])
C0428883 (UMLS CUI [3])
Hypercholesterolemia | Serum total cholesterol measurement Random
Item
hypercholesterolemia (random total cholesterol > 6.5 mmol/l)
boolean
C0020443 (UMLS CUI [1])
C1445957 (UMLS CUI [2,1])
C0439605 (UMLS CUI [2,2])
Diabetes Mellitus | Serum fasting glucose measurement | Serum random glucose measurement
Item
diabetes mellitus (fasting glucose > 7.0 mmol/l or random glucose > 11.0 mmol/l)
boolean
C0011849 (UMLS CUI [1])
C0583334 (UMLS CUI [2])
C0583333 (UMLS CUI [3])
Asthma | Dyspnea Recurrent episode | Wheezing Recurrent episode | Inhalation Drug Administration prescribed | Adrenal Cortex Hormones | beta2-Adrenergic Agonist
Item
asthma (recurrent episodes of dyspnea and wheezing, or usage of prescribed inhalation medication: i.e. corticosteroids or b2-agonists)
boolean
C0004096 (UMLS CUI [1])
C0013404 (UMLS CUI [2,1])
C0443287 (UMLS CUI [2,2])
C0043144 (UMLS CUI [3,1])
C0443287 (UMLS CUI [3,2])
C0001559 (UMLS CUI [4,1])
C0278329 (UMLS CUI [4,2])
C0001617 (UMLS CUI [5])
C2917450 (UMLS CUI [6])
Study Subject Participation Status
Item
participation in any clinical trial during the last 60 days prior to this study.
boolean
C2348568 (UMLS CUI [1])
Annexin A5 Dose Quantity
Item
administration of two doses of annexin a5 (0,1mg; 450mbq) during the last 5 years prior to this study.
boolean
C0059249 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial